切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2018, Vol. 07 ›› Issue (01) : 83 -86. doi: 10.3877/cma.j.issn.2095-3224.2018.01.018

所属专题: 经典病例 文献

教训与反思

直肠腺癌合并原发性肝脏神经内分泌癌一例
陈颖1, 孟雅楠1, 刘云鹏1, 刘静1, 金波1,()   
  1. 1. 110001 沈阳,中国医科大学附属第一医院肿瘤内科
  • 收稿日期:2017-07-27 出版日期:2018-02-25
  • 通信作者: 金波
  • 基金资助:
    辽宁省中央引导地方科技发展专项资金(No.2016007010); 辽宁省科学技术计划项目(No.2014226033、No.2014225013); 辽宁省卫生计生委赞助项目(No.LNCCC-D07-2015)

A case report of rectal adenocarcinoma with primary neuroendocrine carcinoma of the liver

Ying Chen1, Yanan Meng1, Yunpeng Liu1, Jing Liu1, Bo Jin1,()   

  1. 1. Department of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China
  • Received:2017-07-27 Published:2018-02-25
  • Corresponding author: Bo Jin
  • About author:
    Corresponding author: Jin Bo, Email:
引用本文:

陈颖, 孟雅楠, 刘云鹏, 刘静, 金波. 直肠腺癌合并原发性肝脏神经内分泌癌一例[J]. 中华结直肠疾病电子杂志, 2018, 07(01): 83-86.

Ying Chen, Yanan Meng, Yunpeng Liu, Jing Liu, Bo Jin. A case report of rectal adenocarcinoma with primary neuroendocrine carcinoma of the liver[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2018, 07(01): 83-86.

原发性肝脏神经内分泌癌较为少见,临床表现和影像学不具有特异性,病理诊断为金标准。该病例中患者同时伴有直肠腺癌,在初诊时肝内病灶考虑肠癌转移。在肝脏病灶与直肠病灶评效不一致后,我们行肝脏病灶穿刺病理证实为原发性肝脏神经内分泌癌,但由于患者肝功异常及体力下降未再有治疗机会。该病例提示我们临床工作中需要警惕患者存在多重癌可能,并且获得病理诊断很重要。

Primary hepatic neuroendocrine carcinoma is a rare disease and is short of specific clinical and imaging features. The pathological diagnosis is the gold standard. In this case, the patient presented with rectal adenocarcinoma with multiple liver lesions, which were thought as metastases from rectal cancer. Under the treatment, the primary rectal tumor responded well to the chemotherapy, while the liver lesions progressed rapidly. A biopsy to the liver was then performed, and the pathologic diagnosis revealed primary hepatic neuroendocrine carcinoma. Because of abnormal liver function and poor performance status, the patient was not tolerable for further treatment. This case indicated that we should be aware of the posibility of multiple cancers in clinical work.

图1 腹部增强CT表现:图1A1,1B1,1C1,2016年5月3日治疗前肝脏病灶;图2A2,2B2,2C2,2016年6月27日XELOX化疗2周期后肝脏病灶评效疾病进展;图3A3,3B3,3C3,2016年7月24日患者死亡前1天检查,提示疾病再次进展
图2 直肠及肝脏病变病理结果:2A直肠腺癌HE染色;2B肝脏穿刺标本HE40倍;2C肝穿刺标本免疫组化GgA(+);2D肝脏穿刺标本免疫组化CD56(+);2E肝脏穿刺标本HE20倍;2F肝脏穿刺病理免疫Ki67(+75%)
[1]
ParK CH, Chung JW, Jang SJ, et al. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas [J]. J Gastroenterol Hepatol, 2012, 27(8): 1306-1311.
[2]
陈万青,郑荣寿,曾红梅, 等. 1989-2008年中国恶性肿瘤发病趋势分析 [J]. 中华肿瘤杂志, 2012, 34(7): 517-524.
[3]
Mima K, Beppu T, Murata A, et al. Primary neuroendocrine tumor in the liver treated by hepatectomy: report of a case [J]. Surg Today, 2011, 41(12): 1655-1660.
[4]
Hasegawa H, Kuzushita N, Nakazuru S, et al. Case of primaryhepatic neuroendocrine carcinoma diagnosed by needle biopsy [J]. Nihon Shokakibyo Gakkai Zasshi, 2010, 107(12): 1956-1962.
[5]
Volante M, Righi L, Berruti A, et al. The pathological diagnosis Of neuroendocrine tumors: common questions and tentative answers [J]. Virchows Arch, 2011, 458(4): 393-402.
[6]
Huang YQ, Xu F, Yang JM, et al. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases [J]. Hepatobiliary Pancreat Dis Int, 2010, 9(1): 44-48.
[7]
Van der Hoef M, Crook DW, Marincek B, et al. Primary neuroendocrine tumors of the liver: MRI features in two cases [J]. Abdom Imaging, 2004, 29(1): 77-81.
[8]
Kong W, Qiu Y, Zhang W, et al. Diagnosis of primary hepatic carcinoid tumor: report of one case [J]. Chin-Ger J Clin Oncol , 2008, 7(11): 673-675.
[9]
Chen Z, Xiao HE, Ramchandra P, et al. Imaging and pathological features of primary hepatic neuroendocrine carci- noma: an analysis of nine cases and review of the literature [J]. Oncol Lett, 2014, 7(4): 956-962.
[10]
Yao J, Hassan MA, Dagohoy C, et al. One hundred years after ″carcinoid″: epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States [J]. J Clini Oncol, 2008, 26(18): 3063-3072.
[11]
许加刚,李伟,李玲. 47例原发性肝神经内分癌的临床分析 [J]. 中国现代医学, 2013, 51(4): 61-63.
[1] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[2] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[3] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[4] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[5] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[6] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[7] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[8] 付振保, 曹万龙, 刘富红. 腹腔镜直肠癌低位前切除术中不同缝合方法的回肠双腔造口术临床效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 684-687.
[9] 贺亮, 王松林, 周业江. 两种预防性回肠造口在腹腔镜ISR术治疗超低位直肠癌的效果对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 697-700.
[10] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[11] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[12] 杨红杰, 张智春, 孙轶. 直肠癌淋巴结转移诊断研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 512-518.
[13] 马慧颖, 凡新苓, 覃仕瑞, 陈佳赟, 曹莹, 徐源, 金晶, 唐源. 磁共振加速器治疗局部晚期直肠癌的初步经验[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 519-523.
[14] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[15] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
阅读次数
全文


摘要